Integrated Hypertension and Diabetes Mellitus Type II Treatment and Care Among People Living With HIV/AIDS

CompletedOBSERVATIONAL
Enrollment

333

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Diabetes MellitusHypertensionHIV Infections
Interventions
DIAGNOSTIC_TEST

Biochemical, weight measurements, Blood pressure and blood sugar level

At first visit short interview using the STEPwise approach of the STEPS surveillance tool for NCDs from the WHO will be conducted. On subsequent visits, hypertension and blood sugar level and cholesterol levels will be measured and adherence to medication will be assessed. The patient's registry will be developed following recommendation from the HEARTS technical package of World Health Organization (WHO) with some modification if needed.

Trial Locations (1)

Unknown

Temeke Regional Referral Hospital, Dar es Salaam

All Listed Sponsors
lead

Muhimbili University of Health and Allied Sciences

OTHER

NCT05786703 - Integrated Hypertension and Diabetes Mellitus Type II Treatment and Care Among People Living With HIV/AIDS | Biotech Hunter | Biotech Hunter